Richard HardyRichard Hardy Email Print 0

Andrew Bynum’s Return Likely Delayed?

By Stephen Brotherston 

The Philadelphia 76ers knew about Andrew Bynum’s history of knee problems when they acquired the 24-year-old center this summer and it doesn’t appear to have come as much of a surprise that the big man was going to require treatments prior to the start of the season. However, the plan to inject both of Bynum’s knees with Synvisc-One on Monday, October 22 could delay Bynum’s return to the lineup, or even the practice court, a lot longer than team officials are letting on.

According to the company website, Synvisc-One is designed to treat Osteoarthritis, a common form of arthritis pain in the knee. Pain and stiffness is caused by the cartilage protecting the ends of the bones deteriorating and the joint fluid losing its shock-absorbing qualities. Synvisc-One supplements a person’s own joint fluid and can provide up to six months of relief.

However, Synvisc-One takes four weeks after the injection before most patients experience pain relief, there can be side effects such as swelling or fluid buildup and 29 percent of patients do not experience pain relief as a result of the procedure.

Click Here For More

 

Beal Adjusting to NBA Without Wall

By Alex Raskin

It wasn’t that the Washington Wizards needed more depth in the backcourt. If nothing else, the team already had lightening-fast point guard John Wall

View the Original article